Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium
Patients with cardiovascular disease and diabetes are at potentially higher risk of infection and fatality due to COVID-19. Given the social and economic costs associated with disability due to these conditions, it is imperative that specific considerations for clinical management of these patients...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2020-06-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fcvm.2020.00112/full |
| _version_ | 1818925827405905920 |
|---|---|
| author | Sonu Bhaskar Sonu Bhaskar Sonu Bhaskar Sonu Bhaskar Sonu Bhaskar Aarushi Rastogi Aarushi Rastogi Aarushi Rastogi Vijay Kumar Chattu Vijay Kumar Chattu Anil Adisesh Anil Adisesh Pravin Thomas Pravin Thomas Negman Alvarado Negman Alvarado Anis D. Riahi Anis D. Riahi Chakrakodi N. Varun Chakrakodi N. Varun Anupama R. Pai Anupama R. Pai Sarah Barsam Sarah Barsam Antony H. Walker Antony H. Walker |
| author_facet | Sonu Bhaskar Sonu Bhaskar Sonu Bhaskar Sonu Bhaskar Sonu Bhaskar Aarushi Rastogi Aarushi Rastogi Aarushi Rastogi Vijay Kumar Chattu Vijay Kumar Chattu Anil Adisesh Anil Adisesh Pravin Thomas Pravin Thomas Negman Alvarado Negman Alvarado Anis D. Riahi Anis D. Riahi Chakrakodi N. Varun Chakrakodi N. Varun Anupama R. Pai Anupama R. Pai Sarah Barsam Sarah Barsam Antony H. Walker Antony H. Walker |
| author_sort | Sonu Bhaskar |
| collection | DOAJ |
| description | Patients with cardiovascular disease and diabetes are at potentially higher risk of infection and fatality due to COVID-19. Given the social and economic costs associated with disability due to these conditions, it is imperative that specific considerations for clinical management of these patients be observed. Moreover, the reorganization of health services around the pandemic response further exacerbates the growing crisis around limited access, treatment compliance, acute medical needs, and mental health of patients in this specific subgroup. Existing recommendations and guidelines emanating from respective bodies have addressed some of the pressure points; however, there are variations and limitations vis a vis patient with multiple comorbidities such as obesity. This article will pull together a comprehensive assessment of the association of cardiovascular disease, diabetes, obesity and COVID-19, its impact on the health systems and how best health systems can respond to mitigate current challenges and future needs. We anticipate that in the context of this pandemic, the cardiovascular disease and diabetes patients need a targeted strategy to ensure the harm to this group does not translate to huge costs to society and to the economy. Finally, we propose a triage and management protocol for patients with cardiovascular disease and diabetes in the COVID-19 settings to minimize harm to patients, health systems and healthcare workers alike. |
| first_indexed | 2024-12-20T02:47:25Z |
| format | Article |
| id | doaj.art-7813b2061f8a44888b5203b98341c60b |
| institution | Directory Open Access Journal |
| issn | 2297-055X |
| language | English |
| last_indexed | 2024-12-20T02:47:25Z |
| publishDate | 2020-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Cardiovascular Medicine |
| spelling | doaj.art-7813b2061f8a44888b5203b98341c60b2022-12-21T19:56:08ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2020-06-01710.3389/fcvm.2020.00112552686Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM ConsortiumSonu Bhaskar0Sonu Bhaskar1Sonu Bhaskar2Sonu Bhaskar3Sonu Bhaskar4Aarushi Rastogi5Aarushi Rastogi6Aarushi Rastogi7Vijay Kumar Chattu8Vijay Kumar Chattu9Anil Adisesh10Anil Adisesh11Pravin Thomas12Pravin Thomas13Negman Alvarado14Negman Alvarado15Anis D. Riahi16Anis D. Riahi17Chakrakodi N. Varun18Chakrakodi N. Varun19Anupama R. Pai20Anupama R. Pai21Sarah Barsam22Sarah Barsam23Antony H. Walker24Antony H. Walker25Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, CVD and Metabolic REPROGRAM Sub-committee†, Sydney, NSW, AustraliaLiverpool Hospital & South West Sydney Local Health District (SWSLHD), Department of Neurology & Neurophysiology, Sydney, NSW, AustraliaNeurovascular Imaging Laboratory, Ingham Institute for Applied Medical Research, Clinical Sciences Stream, Sydney, NSW, AustraliaNSW Brain Clot Bank, NSW Health Statewide Biobank, Sydney, NSW, AustraliaSouth Western Sydney Clinical School, University of New South Wales (UNSW), Sydney, NSW, AustraliaPandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, CVD and Metabolic REPROGRAM Sub-committee†, Sydney, NSW, AustraliaNeurovascular Imaging Laboratory, Ingham Institute for Applied Medical Research, Clinical Sciences Stream, Sydney, NSW, AustraliaSouth Western Sydney Clinical School, University of New South Wales (UNSW), Sydney, NSW, AustraliaPandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, CVD and Metabolic REPROGRAM Sub-committee†, Sydney, NSW, AustraliaDepartment of Medicine, St. Michael's Hospital, University of Toronto, Toronto, ON, CanadaPandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, CVD and Metabolic REPROGRAM Sub-committee†, Sydney, NSW, AustraliaDepartment of Medicine, St. Michael's Hospital, University of Toronto, Toronto, ON, CanadaPandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, CVD and Metabolic REPROGRAM Sub-committee†, Sydney, NSW, AustraliaUniversity Hospitals Birmingham NHS Foundation Trust, Birmingham, United KingdomPandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, CVD and Metabolic REPROGRAM Sub-committee†, Sydney, NSW, AustraliaDepartment of Neurophysiology, Instituto Médico Dr. Rodriguez Alfici, Godoy Cruz, ArgentinaPandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, CVD and Metabolic REPROGRAM Sub-committee†, Sydney, NSW, AustraliaDepartment of Neurology, Faculty of Medicine, Military Hospital of Tunis, University of Tunis El Manar, Tunis, TunisiaPandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, CVD and Metabolic REPROGRAM Sub-committee†, Sydney, NSW, Australia0State Level Virus Research and Diagnostics Laboratory, Bangalore Medical College and Research Institute, Bengaluru, IndiaPandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, CVD and Metabolic REPROGRAM Sub-committee†, Sydney, NSW, Australia1Department of Neuromicrobiology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, IndiaPandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, CVD and Metabolic REPROGRAM Sub-committee†, Sydney, NSW, Australia2Department of Hematology, North Middlesex Hospital, King's Thrombosis Center & King's College Hospital NHS Foundation Trust, King's College London, London, United KingdomPandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, CVD and Metabolic REPROGRAM Sub-committee†, Sydney, NSW, Australia3Department of Cardiothoracic Surgery, Lancashire Cardiac Centre, Blackpool Victoria Hospital, NHS, Blackpool, United KingdomPatients with cardiovascular disease and diabetes are at potentially higher risk of infection and fatality due to COVID-19. Given the social and economic costs associated with disability due to these conditions, it is imperative that specific considerations for clinical management of these patients be observed. Moreover, the reorganization of health services around the pandemic response further exacerbates the growing crisis around limited access, treatment compliance, acute medical needs, and mental health of patients in this specific subgroup. Existing recommendations and guidelines emanating from respective bodies have addressed some of the pressure points; however, there are variations and limitations vis a vis patient with multiple comorbidities such as obesity. This article will pull together a comprehensive assessment of the association of cardiovascular disease, diabetes, obesity and COVID-19, its impact on the health systems and how best health systems can respond to mitigate current challenges and future needs. We anticipate that in the context of this pandemic, the cardiovascular disease and diabetes patients need a targeted strategy to ensure the harm to this group does not translate to huge costs to society and to the economy. Finally, we propose a triage and management protocol for patients with cardiovascular disease and diabetes in the COVID-19 settings to minimize harm to patients, health systems and healthcare workers alike.https://www.frontiersin.org/article/10.3389/fcvm.2020.00112/fullcoronavirus disease 2019 (COVID-19)healthcare servicescardiovascular diseases (CVDs)diabetesobesitypersonal protective equipment (PPE) |
| spellingShingle | Sonu Bhaskar Sonu Bhaskar Sonu Bhaskar Sonu Bhaskar Sonu Bhaskar Aarushi Rastogi Aarushi Rastogi Aarushi Rastogi Vijay Kumar Chattu Vijay Kumar Chattu Anil Adisesh Anil Adisesh Pravin Thomas Pravin Thomas Negman Alvarado Negman Alvarado Anis D. Riahi Anis D. Riahi Chakrakodi N. Varun Chakrakodi N. Varun Anupama R. Pai Anupama R. Pai Sarah Barsam Sarah Barsam Antony H. Walker Antony H. Walker Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium Frontiers in Cardiovascular Medicine coronavirus disease 2019 (COVID-19) healthcare services cardiovascular diseases (CVDs) diabetes obesity personal protective equipment (PPE) |
| title | Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium |
| title_full | Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium |
| title_fullStr | Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium |
| title_full_unstemmed | Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium |
| title_short | Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium |
| title_sort | key strategies for clinical management and improvement of healthcare services for cardiovascular disease and diabetes patients in the coronavirus covid 19 settings recommendations from the reprogram consortium |
| topic | coronavirus disease 2019 (COVID-19) healthcare services cardiovascular diseases (CVDs) diabetes obesity personal protective equipment (PPE) |
| url | https://www.frontiersin.org/article/10.3389/fcvm.2020.00112/full |
| work_keys_str_mv | AT sonubhaskar keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT sonubhaskar keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT sonubhaskar keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT sonubhaskar keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT sonubhaskar keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT aarushirastogi keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT aarushirastogi keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT aarushirastogi keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT vijaykumarchattu keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT vijaykumarchattu keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT aniladisesh keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT aniladisesh keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT pravinthomas keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT pravinthomas keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT negmanalvarado keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT negmanalvarado keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT anisdriahi keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT anisdriahi keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT chakrakodinvarun keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT chakrakodinvarun keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT anupamarpai keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT anupamarpai keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT sarahbarsam keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT sarahbarsam keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT antonyhwalker keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium AT antonyhwalker keystrategiesforclinicalmanagementandimprovementofhealthcareservicesforcardiovasculardiseaseanddiabetespatientsinthecoronaviruscovid19settingsrecommendationsfromthereprogramconsortium |